The estimated Net Worth of Capital, Llc J Ven is at least $7.69 Миллион dollars as of 19 May 2016. Capital Ven owns over 874,317 units of Opgen Inc stock worth over $7,687,320 and over the last 8 years Capital sold OPGN stock worth over $0.
Capital has made over 1 trades of the Opgen Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Capital bought 874,317 units of OPGN stock worth $1,766,120 on 19 May 2016.
The largest trade Capital's ever made was buying 874,317 units of Opgen Inc stock on 19 May 2016 worth over $1,766,120. On average, Capital trades about 437,159 units every 0 days since 2016. As of 19 May 2016 Capital still owns at least 3,805,604 units of Opgen Inc stock.
You can see the complete history of Capital Ven stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 11009 CRIPPLEGATE ROAD, , POTOMAC, MD, 20854.
Over the last 9 years, insiders at Opgen Inc have traded over $12,018 worth of Opgen Inc stock and bought 4,331,782 units worth $1,198,700 . The most active insiders traders include Evan/ Fa Jones, Capital, Llcjones Evan/ Fa ... и Capital, Llc J Ven. On average, Opgen Inc executives and independent directors trade stock every 78 days with the average trade being worth of $280,277. The most recent stock trade was executed by Johannes Bacher on 31 March 2023, trading 6,434 units of OPGN stock currently worth $12,997.
opgen, inc. (nasdaq: opgn) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment. using our large and ever-growing acuitas lighthouse® knowledgebase of pathogens from around the world, we are developing disruptive technologies aimed to shift the paradigm for managing infectious diseases. today, through our clia-certified clinical laboratory services, we provide rapid detection and analysis of antibiotic resistance and high resolution microbial sequence analysis. our fda-cleared, ivd products rapidly identify pathogens in positive blood cultures.
Opgen Inc executives and other stock owners filed with the SEC include: